drugset / Trial / NCT00564421

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

NCT00564421

Phase 3 Completed 798 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of epinastine nasal spray compared to placebo for the treatment of subjects with seasonal allergic rhinitis

Timeline

Start
2007-12-18
Primary completion
2008-02-14
Completion
2008-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinastine Small molecule Intranasal